ACE Inhibitors and Primary Aldosteronism Diagnosis
If your patient is on ACE inhibitors, you can proceed with aldosterone-to-renin ratio (ARR) screening without stopping the medication, but you must interpret results knowing that ACE inhibitors increase renin and decrease aldosterone, which lowers the ARR and can cause false-negative results. 1, 2
Understanding the Drug Effect
ACE inhibitors interfere with ARR testing by:
- Increasing plasma renin activity significantly 3, 4
- Decreasing aldosterone levels to a minor extent 5
- Lowering the ARR, which can mask primary aldosteronism 2, 3
The net effect is that ACE inhibitors cause false-negative screening results in patients who actually have primary aldosteronism. 1, 2
Practical Management Options
Option 1: Test on Current Medications (Preferred for Safety)
Test while the patient continues ACE inhibitors and interpret results in the context of known drug effects. 1, 2
- If ARR is positive despite ACE inhibitor use (ARR ≥30 with aldosterone ≥10 ng/dL), this is highly specific for primary aldosteronism since the drug should have lowered the ratio 1
- If ARR is negative, you cannot rule out primary aldosteronism—the result may be falsely negative 2, 3
- This approach prioritizes patient safety by avoiding uncontrolled hypertension during medication withdrawal 2
Option 2: Switch to Non-Interfering Medications
Replace ACE inhibitors with calcium channel blockers (verapamil slow-release), alpha-blockers (doxazosin, prazosin), or hydralazine for 2-4 weeks before testing. 1, 4
- These medications minimally interfere with ARR and maintain blood pressure control 1, 4
- Calcium channel blockers have no significant influence on aldosterone or renin 5
- Doxazosin causes only -5% change in ARR compared to -30% with ACE inhibitors 4
- Do not use beta-blockers as substitutes—they suppress renin and cause false-positive results 1, 5
Option 3: Withdraw ACE Inhibitors (When Clinically Safe)
Stop ACE inhibitors for 2 weeks minimum before testing if blood pressure can be safely controlled with non-interfering agents. 1, 6
- Traditional guidelines recommend 4-6 weeks, but recent evidence shows 2 weeks is sufficient if renin suppression is confirmed 6
- Ensure adequate blood pressure control during withdrawal with alternative agents 1
- This approach provides the most accurate ARR results 2
Critical Pitfall to Avoid
Never rely on a negative ARR result in a patient taking ACE inhibitors to rule out primary aldosteronism. 2, 3
In one study, ACE inhibitor therapy caused false-negative results in 16-28% of patients with confirmed primary aldosteronism. 3 If clinical suspicion remains high (resistant hypertension, hypokalemia, adrenal mass), either switch medications and retest or proceed directly to confirmatory testing. 1
Alternative Diagnostic Approach
Research suggests the aldosterone/angiotensin II ratio may be superior to ARR in patients on ACE inhibitors, as it remains elevated in primary aldosteronism despite ACE inhibitor use. 3 However, this test requires specialized liquid chromatography-tandem mass spectrometry and is not widely available in clinical practice. 3
When Confirmatory Testing is Needed
If you proceed with screening on ACE inhibitors and get a positive result, withdraw ACE inhibitors for at least 2 weeks before confirmatory testing (saline suppression or oral sodium loading). 1, 6 Confirmatory tests require demonstration of autonomous aldosterone secretion that cannot be suppressed, and ACE inhibitors will interfere with this assessment. 1